Preeti M Chincholikar

Preeti M Chincholikar

Active Director Designated Partner DIN 07743290
DIN 07743290 First appointment Mar 2017 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Preeti M Chincholikar

Data last updated:

Preeti M Chincholikar is a Designated Partner at Shooline Pharmaceuticals Llp (since 2017). The company operates in Business Services.

DIN 07743290
Primary Designation Designated Partner
Industry Business Services
First Appointment 09 Mar 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Mar 20172017Active

Board colleagues of Preeti M Chincholikar

NameDINCompanyDesignation
Manoj Raghavendra Chincholikar07743362Shooline Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Shooline Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Preeti M Chincholikar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Preeti M Chincholikar

Preeti M Chincholikar currently holds 1 directorship: Shooline Pharmaceuticals Llp (Designated Partner, since 09 Mar 2017).

Preeti M Chincholikar was first appointed on 09 Mar 2017 as Designated Partner at Shooline Pharmaceuticals Llp.

The current boards of Preeti M Chincholikar's companies include Manoj Raghavendra Chincholikar (Shooline Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available